Search criteria | ||||
Cost of illness: estimating direct healthcare costs related to obesity in a Japanese clinical setting | ||||
Riku Ota 1, Koki Idehara 2, Hiroyuki Matsuda 2, Ronald Filomeno 2, J Baker-Knight 3 (rwesheorj 2) | ||||
1) Novo Nordisk Pharma Ltd., Nerima, 13, Japan 2) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan 3) Novo Nordisk, 2900, Denmark | ||||
ISPOR Value in Health |
||||
, Abstract, Conference, Poster, Presentation | ||||
, Japan | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2023-3669/124060 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2023 | English | , Cost of illness, Database Study | |
Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: a survey-based study | ||||
Yuta Koto 1, Aya Narita 2, Shinichi Noto 3, Masafumi Okada 4, Midori Ono 5, Terumi Baba 5, Rieko Sagara 5, Norio Sakai 1 (rwesheorj 4) | ||||
1) Child Healthcare and Genetic Science Laboratory, Division of Health Sciences, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka 565-0871, Japan 2) Division of Child Neurology, Institute of Neurological Science, Tottori University Faculty of Medicine, 86 Nishi-cho, Yonago-shi, Tottori 683-8503, Japan 3) Department of Rehabilitation, Niigata University of Health and Welfare, 1398 Shimami-cho, Kita-ku, Niigata-shi, Niigata 950-3198, Japan 4) Real-World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., 4-10-18 Takanawa, Minato-ku, Tokyo 108-0074, Japan 5) Japan Medical Office, Takeda Pharmaceutical Company Limited, 2-1-1 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8688, Japan | ||||
Molecular Genetics and Metabolism Reports |
||||
, Article, Online article | ||||
, Japan | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S221442692300040X?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Neurological disorders | 2023 | English | , Patient questionnaire, Survey research | |
Concomitant Medication Use in the Treatment Journey of Pulmonary Arterial Hypertension Patients: A Canadian Retrospective Claims Analysis | ||||
Essam Ibrahim1, Assem Al-Akabawi1, Moses Dawodu1, Juejing Ling2, Irene Wang2, Brad Millson3 | ||||
1Janssen Canada Inc, Toronto, ON, Canada; 2IQVIA Solutions Canada Inc., Mississauga, ON, Canada; 3IQVIA Solutions Canada Inc., Kanata, ON, Canada | ||||
, Poster | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2022 | English | , Clinical setting: hospital, Clinical setting: Primary care, direct to patient research, Observational study | |
Patient preferences for growth hormone treatment in Japanese children | ||||
Toshiaki Tanaka 1, Takahiro Sato 2, Akira Yuasa 3, Takeshi Akiyama 4, Adeeb Tawseef 4 (rwesheorj 4) | ||||
1) Tanaka Growth Clinic, Tokyo, Japan 2) Medical Affairs, Rare Disease, Pfizer Japan Inc, Tokyo, Japan 3) Corporate Affairs, Health and Value, Pfizer Japan Inc, Tokyo, Japan 4) IQVIA Solutions Japan K.K., RWE & HEOR, Tokyo, Japan | ||||
Pediatrics International |
||||
, Article | ||||
, Japan | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ped.14760 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2021 | English | , Patient questionnaire, Survey research | |
An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in a Prefilled Pen in Germany | ||||
Chen J1, Perez-Nieves M1, Piras De Oliveira C1, Spaepen E2, Osumili B3, Ling Poon J1, Schloot N2, Lara N4, Garcia Alvarez L4, Roset M4, Lennartz D5 | ||||
1 Lilly and Company, Indianapolis, US 2 Eli Lilly and Company Deutschland GmbH, Bad Homburg, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Barcelona, Spain 5 IQVIA, Munich, Germany | ||||
ECE, Lyon, France, 18-21 May 2019 |
||||
, Poster | ||||
, Germany | ||||
Abstract: htpps://doi.org/10.1530/endoabs.63.P207 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2019 | English | , Survey research | |
Cinacalcet Persistence and Adherence in France, Germany, and Italy | ||||
Dionne M. Hines1, Catherine B. McGuiness1, Rolin L. Wade1, Bruno Fouqueray2, Paul Dluzniewski2 | ||||
1QuintilesIMS, 2Amgen | ||||
54th ERA-EDTA Congress |
||||
, Poster | ||||
, France, Germany, Italy | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Nephrology | 2017 | English | , Retrospective database analysis | |
Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice. | ||||
Trifirò G1, Parrino F, Sultana J, Giorgianni F, Ferrajolo C, Bianchini E, Medea G, Benvenga S, Cricelli I, Cricelli C, Lapi F. | ||||
Department of Clinical and Experimental Medicine, Pharmacology section, University of Messina, Messina, Italy | ||||
Clin Drug Investig. 2015 Mar;35(3) |
||||
, Abstract | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2015 | English | , Retrospective database analysis | |
Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan. | ||||
Shortridge EF1, Polzer P2, Donga P3, Wade RL3 | ||||
1 Spine and Biologics, Medtronic Inc., Memphis, TN, USA. 2 Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA. 3 Health Economics and Outcomes Research, IMS Health, Plymouth Meeting, PA, USA. | ||||
Int J Clin Pract. 2015 Jul;69(7):783-90. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Endocrinology | 2015 | English | , Retrospective database analysis | |
Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study | ||||
Karch A & Thomas SL | ||||
Department of Epidemiology (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Faculty of Epidemiology & Population Health (A.K., S.L.T.), London School of Hygiene and Tropical Medicine, UK; and Department of Neurology (A.K.), University Medical Center Göttingen, Germany. | ||||
Neurology. 2014 May 6;82(18):1643-52. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24719488 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Endocrinology, Immunology and Vaccination, Neurological disorders | 2014 | English | , Retrospective database analysis | |
Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women. | ||||
Enrico Papaleo,1 Carlo Alviggi,2 Giorgio Lorenzo Colombo,3,4 Claudio Pisanelli,5,6 Claudio Ripellino,7 Salvatore Longobardi,8 and Pier Luigi Canonico9 | ||||
Centro Scienze della Natalità, Gynecological-Obstetrics Department, San Raffaele Hospital, Vita-Salute San Raffaele, Milan, Italy 2Department of Neuroscience, Reproductive Sciences and Odontostomatology, University “Federico II” of Naples, Naples, Italy 3Department of Drug Sciences, University of Pavia, Pavia, Italy 4SAVE Studi Analisi Valutazioni Economiche, Milan, Italy 5ACO San Filippo Neri, Rome, Italy 6Società Italiana Di Farmacia Ospedaliera, Milan, Italy 7CSD Medical Research Srl, Milan, Italy 8Medical Department, Merck Serono SpA, Rome, Italy 9Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italy | ||||
Ther Clin Risk Manag. 2014 Jun 25;10:479-84 |
||||
, Article | ||||
, Italy | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25028553 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Womens Health | 2014 | English | , Cost effectiveness | |
Diabète de type 2 : quels objectifs thérapeutiques selon les nouvelles recommandations de l’HAS ? Analyse de 6 680 patients suivis par des médecins [Type 2 diabetes: which therapeutic objectives according to the new recommendations of the HAS? Analysis of 6,680 patients followed by doctors]. | ||||
Larger E1, Ansolabehere X2, Grandfils N2, Le Jeunne P2 | ||||
1 GH Cochin Hôtel-Dieu, Paris 2 IMS Health HEOR, La Défense | ||||
Congrès annuel de la Société Francophone du Diabète (SFD). 11-14 mars 2014 Paris |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Endocrinology, Metabolic Disorders | 2014 | French | , Retrospective database analysis | |
Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010 | ||||
Jewett PI, Gangnon RE, Trentham-Dietz A, Sprague BL | ||||
University of Wisconsin | ||||
Obstet Gynecol 2014;124(4):727-733. |
||||
, Abstract | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=postmenopausal+estrogen+plus+progestin+prevalence+in+the+United+States+between+1970+and+2010. | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2014 | English | , Real World Evidence | |
Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers. | ||||
Kremidas D, Wisniewski T, Divino VM, Bala K, Olsen M, Germak J, Aagren M, Holot N, Lee WC. | ||||
Novo Nordsik; IMS authors: Divino V | ||||
J Pediatr Nurs |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/22300524 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2013 | English | , Survey research | |
Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers. | ||||
Kremidas D, Wisniewski T, Divino VM, Bala K, Olsen M, Germak J, Aagren M, Holot N, Lee WC. | ||||
Novo Nordsik; IMS authors: Divino V | ||||
J Pediatr Nurs |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/22300524 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2013 | English | , Survey research | |
Improvements in Health-Related Quality of life in Acromegaly with Pasireotide LAR and Octreotide LAR: Results from a large, randomized, Double-Blind Phase III Trial | ||||
Badia X1, Forsythe A2, Nelson LM3, Coles TM3, McLeod LD3, Webb SM4 | ||||
1IMS Health, Barcelona, Barcelona, Spain, 2Novartis Pharmaceuticals, East Hanover, NJ, USA, 3RTI Health Solutions, Research Triangle Park, NC, USA, 4Hospital Sant Pau and CIBERER 747, Universitat Autònoma de Barcelona, Barcelona, Spain | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2012 | English | , Prospective study | |
Chart Audit and Budget impact analysis of Pasireotide versus second-line therapies in the treatment of Cushing´s disease in Germany | ||||
Badia X1, Forsythe A2, Stemmer V3, Cummins G4 | ||||
1IMS Health, Barcelona, Barcelona, Spain, 2Novartis Pharmaceuticals, East Hanover, NJ, USA, 3Novartis Pharma GmbH, Nuremberg, Germany, 4Quintiles Consulting, Hawthorne, NY, USA | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Germany | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2012 | English | , Budget impact | |
Psychometric performance of the CushingQol questionnaire in conditions of real clinical practice. | ||||
Santos A, Resmini E, Martínez-Momblán MªA, Crespo I, Valassi E, Roset M, Badia X, Webb S. | ||||
Health Economics and Outcomes Research, IMS Health, Barcelona, Hospital Sant Pau, Center of Biomedical Investigation in rare diseases. | ||||
Eur J Endocrinol. 2012 Sep;167(3):337-42 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Psychometric%20performance%20of%20the%20CushingQol%20questionnaire%20in%20conditions%20of%20real%20clinical%20practice. | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2012 | English | , Quality of life | |
Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing’s syndrome: cohort study. | ||||
Fardet L, Petersen I & Nazareth I. | ||||
UCL MRC General Practice Research Framework | ||||
BMJ2012; 345 doi: http://dx.doi.org/10.1136/bmj.e4928(Published 30 July 2012) BMJ: 345:e4928 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.bmj.com/content/345/bmj.e4928 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Endocrinology | 2012 | English | , Retrospective database analysis | |
Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. | ||||
Fardet L, Petersen I & Nazareth I | ||||
Medical Research Council General Practice Research Framework | ||||
Am J Psychiatry. 2012 May;169(5):491-7. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22764363 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Mental health | 2012 | English | , Retrospective database analysis | |
Severe hypertriglyceridaemia in patients treated with lipid-modifying agents. | ||||
Désaméricq G1, Van Ganse E1, Schwalm MS2, Bourke A3, Moulin P4. | ||||
1Unité de pharmaco-épidémiologie, faculté d’odontologie UCBL, CHU de Lyon, 69372 Lyon, France 2Cegedim Strategic Data, 92100 Boulogne-Billancourt, France 3The Health Improvement Network, SW8 3QJ London, UK 4Université de Lyon, 69003 Lyon, France Inserm, U870, IFR62, 69008 Lyon, France Inra, UMR1235, 69008 Lyon, France INSA-Lyon, RMND, 69621 Villeurbanne, France Hospices Civils de Lyon, 69008 Lyon, France | ||||
Diabetes & Metabolism Volume 38, n° 3 pages 277-279 (juin 2012) |
||||
, Article | ||||
, Belgium, France, Germany, Italy, UK | ||||
Abstract: http://www.em-consulte.com/en/article/735594 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders , Vascular disease | 2012 | English | , Retrospective database analysis | |
Risk of cardiovascular events in patients with neuroendocrine tumors | ||||
Chen CC1, Hess GP1, Liu Z2, Yao JC3, Phan AT3, Hill JW1. | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX,USA | ||||
Neuroendocrinology 2011;94(Suppl.1;abstract) |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2011 | English | , Retrospective database analysis | |
Risk of hepatic and gastrointestinal events in patients with neuroendocrine tumors | ||||
Hess GP1, Chen CC1, Liu Z2, Yao JC3, Phan AT3, Hill JW1 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA | ||||
Neuroendocrinology 2011;94(Suppl.1;abstract) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2011 | English | , Retrospective database analysis | |
Risk of anxiety/depression events in patients newly diagnosed with neuroendocrine tumors | ||||
Chen CC1, Hess GP1, Liu Z2, Yao JC3, Phan AT3, Hill JW1 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA | ||||
J Clin Oncol 29: 2011 (suppl; abstr e16591) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2011 | English | , Retrospective database analysis | |
Risk of osteoporosis/osteopenia events in patients newly diagnosed with neuroendocrine tumors. | ||||
Hill JW1, Chen CC1, Hess GP1, Satram-Hoang S2, Reyes CM2 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Genentech, South San Francisco, USA | ||||
J Clin Oncol 29: 2011 (suppl; abstr e16602) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2011 | English | , Retrospective cohort analysis | |
Prevalence of the Metabolic Syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain. | ||||
Rodríguez A, Polavieja P, Reviriego J. | ||||
Endocrinol Nutr. 2010; 57(45):60-70. |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2010 | Spanish | , Burden of illness | |
Direct medical cost of Crohn disease in Spain. | ||||
Casellas F, Panés J, García-Sanchez V, Ginard D, Gomollón F, Hinojosa J, Marín-Jiménez I, Barreiro M, Bastida G, Lindner L, Giménez E, Vieta A. | ||||
Pharmacoeconomics Spanish Research Articles 2010;7(5):38-46. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://adisonline.com/pecspanish/Articles/Vol%207%20Issue%201%20page%2038-46%202010.pdf | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2010 | Spanish | , Cost consequence | |
Characteristics and LDL-C Therapeutic Objectives of Patients Receiving Unusual Lipid-Modifying Therapy Regimen | ||||
Desamericq G, Laforest L, Schwalm MS, Bourke A, Broquet M, Van Ganse E & Moulin P | ||||
Cegedim | ||||
ICPE 2010 Pharmacoepidemiology and Drug Safety (19): S1-S347 |
||||
, Abstract, Poster | ||||
, France, UK | ||||
Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/13 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders , Miscellaneous | 2010 | English | , Retrospective database analysis | |
Cost-effectiveness of Rituximab combined with fludarabine and cyclophosphamide in previously untreated patients with chronic lymphocytic leukemia in France | ||||
M. Roussel, X. Troussard, MD, A. Delmer, M. Poinso, H. Miadi Fargier | ||||
ISPOR PARIS 2009 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2009 | English | , Cost effectiveness | |
Health care costs and utilization associated with treatment modification in type 2 diabetes mellitus (T2DM) patients taking oral anti-diabetic drugs (OADs). | ||||
Krishnarajah G1, Bhosle M2, Chapman RH2 | ||||
1 Bristol-Myers Squibb, Princeton, NJ, USA 2 IMS Health, Inc., Falls Church, VA, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research 13th Annual International Meeting, 2009, May 16-20, Orlando, FL, USA |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2009 | English | , Retrospective cohort analysis | |
Relevant outcomes in type 2 diabetes. | ||||
Vieta A, Badia X, Sacristán JA. | ||||
Vieta A1, Badia X1, Sacristán JA2. 1 IMS Health Spain HEOR 2 Lilly Spain | ||||
, Book chapter | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2009 | English | ||
Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study. | ||||
Sjöberg Bexelius T, García Rodríguez LA & Lindblad M | ||||
Department of Molecular Medicine and Surgery, Unit of Esophageal and Gastric Research (ESOGAR), Karolinska Institutet, Solna, Stockholm | ||||
Pancreatology. 2009;9(6):786-92. doi: 10.1159/000225906. Epub 2010 Jan 21. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20110746 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Gastrointestinal disorders | 2009 | English | , Retrospective database analysis | |
Comparison of prescription patterns of statins in primary care in five European countries: results from the LIPIDE observational survey | ||||
Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al | ||||
ICPE/ISPE, Providence. 2009 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
Can the relationship between age and cholesterol levels indicate effectiveness of lipid lowering therapy in primary care? France, Germany, Italy and UK | ||||
Blak BT, Hards M, Maguire A & Schwalm MS | ||||
Cegedim | ||||
ISPOR Orlando, USA Value in Health 12(3):A142-A143 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy, UK | ||||
Abstract: https://www.infona.pl/resource/bwmeta1.element.elsevier-ef0c58f0-1c99-3554-8596-1bce21118531 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
LDL-C goal attainment according to prescribed lipid-lowering therapy: results from the LIPIDE European survey | ||||
Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al | ||||
Université Paris Est, Faculté de Médecine, Créteil, France; | ||||
ICPE/ISPE, Providence. 2009 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
. Prise en charge des patients dyslipidémiques dans cinq pays européens: Résultats préliminaires de l’étude LIPIDE. | ||||
Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al. | ||||
Université Paris Est, Faculté de Médecine, Créteil, France; | ||||
ADELF, Paris. 2009. [French] |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire | ||||
Webb SM1, Badia X2, Barahona MJ3, Colao A3, Strasburger CJ4 Tabarin A5 van Aken MO5 Pivonello R3 Stalla G5 Lamberts SWJ, Glusman JE. | ||||
1Department of Endocrinology, Hospital Sant Pau, Centre for Biomedical Research on Rare Diseases (CIBERER Unit 747), Barcelona, Spain, 2Health Economics and Outcomes Research, IMS Health, 3Department of Endocrinology, Charite´-Universita¨tsmedizin, Berlin, Germany, 4Department of Endocrinology, Centre Hospitalier Universitaire de Bordeaux, , France, 5Department of Internal Medicine, Rotterdam, The Netherlands, 6Department of Endocrinology, Munich, Germany and 7Oncology Clinical Research, Novartis Pharmaceuticals Corporation, New Jersey, USA | ||||
Eur J Endocrinol 2008;158:623-30 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.eje-online.org/cgi/content/abstract/158/5/623 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2008 | English | ||
Quality of Life in Acromegalic Patients during long-term Somatostatin Analog Treatment with and without Pegvisomant | ||||
Neggers SJ1, van Aken MO1, de Herder WW1, Feelders RA1, Janssen JA1, Badia X2, Webb SM3, van der Lely AJ1 | ||||
1Department of Internal Medicine, Erasmus University MC Rotterdam, PO box 2040, 3000 CA, Rotterdam, the Netherlands. 2 Health Economics and Outcomes Research, IMS Health, Barcelona, and Centre for Biomedical Research on Rare Diseases (CIBERER Unit 747), Spain. 3 Department of Endocrinology, Hospital Sant Pau, Autonomous University of Barcelona and Centre for Biomedical Research on Rare Diseases (CIBERER Unit 747), Spain. | ||||
Journal of Clinical Endocrinology & Metabolism 2008;93(10):3853-9 |
||||
, Online article | ||||
, Spain | ||||
Abstract: http://jcem.endojournals.org/cgi/content/abstract/93/10/3853 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2008 | English | , Quality of life | |
Treatment of acromegaly improves quality of life, measured by AcroQol | ||||
Paisley AN1, Rowles SV1, Roberts ME1, Webb SM2, Badia X3, Prieto L4,Shalet SM1, Trainer PJ1 | ||||
1 Department of Endocrinology, Christie Hospital, Wilmslow Road, Manchester, UK, 2 Hospital Sant Pau, Autonomous University of Barcelona, Padre Claret, Barcelona, 3 Health Outcomes Research Europe Group, Barcelona, Spain, 4 HealthOutcomes Consultant, Madrid, Spain | ||||
Clin Endocrinol (Oxf). 2007;67(3):358-62 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2007 | English | , Quality of life | |
Quality of life in growth hormone deficiency and acromegaly | ||||
Webb S, Badia X | ||||
Endocrinol Metab Clin N Am 2007;36:221-32 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2007 | English | , Quality of life | |
Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? | ||||
Koltowska-Häggström M, Mattsson A, Monson P, Kind P, Badia X, Casanueva F, Busschbach J, Koppeschaar HPF, Johannsson G. | ||||
Eur J Endocrinol;155:109-19 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2006 | English | ||
A European prospective real-life observational study of Quality of Life in patients with Acromegaly. | ||||
Webb S, Colao A, Caron Ph, Carvalheiro M, Erturk E, Pokrajac-Simeunovic A, Schopohl J, Tsagarakis S, Pearson I, Badia X, Caglio S, Vincenzi B. | ||||
8th European Congress of Endocrinology (ECE2006), Glasgow (UK) 1-5 April |
||||
, Oral presentation | ||||
, Europe | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2006 | English | ||
A regional Asian analysis of the cost-effectiveness of early irbesartan treatment verus conventional antihypertension treatment, and late irbesartan treatment in patients with type 2 diabetes hypertension and kidney disease | ||||
Annemans L, Demarteau N, Hu S, Lee TJ, Morad Z, Thanom S, Yang WC. | ||||
ISPOR 2nd Asia-Pacific conference, Worldfield Convention Hotel, Shanghai, China |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Nephrology | 2006 | English | ||
Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study | ||||
Mortimer K, Tata LJ , Smith CJP, West J, Harrison TW , Tattersfield A & Hubbard R | ||||
Division of Respiratory Medicine, Nottingham City Hospital | ||||
Thorax. 2006 May;61(5):405-8. Epub 2006 Mar 3. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/16517576 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2006 | English | , Retrospective database analysis | |